399 related articles for article (PubMed ID: 14558293)
1. Electropharmacological effects of antiarrhythmic drugs on atrial fibrillation termination. Part I: Molecular and ionic fundamentals of antiarrhythmic drug actions.
Calò L; Sciarra L; Lamberti F; Loricchio ML; Castro A; Bianconi L; Pandozi C; Gaita F; Santini M
Ital Heart J; 2003 Jul; 4(7):430-41. PubMed ID: 14558293
[TBL] [Abstract][Full Text] [Related]
2. Electropharmacological effects of antiarrhythmic drugs on atrial fibrillation termination. Part II: New insights into the electrophysiological mechanisms of atrial fibrillation termination.
Calò L; Sciarra L; Lamberti F; Loricchio ML; Castro A; Bianconi L; Pandozi C; Gaita F; Santini M
Ital Heart J; 2003 Jul; 4(7):442-7. PubMed ID: 14558294
[TBL] [Abstract][Full Text] [Related]
3. Electrophysiology of atrial fibrillation: evolving insights.
Calò L; Pandozi C; Lamberti F; Riccardi R; Loricchio ML; Castro A; Gaita F; Santini M
Ital Heart J; 2000 Aug; 1(8):521-31. PubMed ID: 10994932
[TBL] [Abstract][Full Text] [Related]
4. Novel pharmacological therapies for atrial fibrillation.
Bagwe S; Leonardi M; Bissett J
Curr Opin Cardiol; 2007 Sep; 22(5):450-7. PubMed ID: 17762547
[TBL] [Abstract][Full Text] [Related]
5. New antiarrhythmic agents for atrial fibrillation and atrial flutter.
Pecini R; Elming H; Pedersen OD; Torp-Pedersen C
Expert Opin Emerg Drugs; 2005 May; 10(2):311-22. PubMed ID: 15934869
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacological restoration and maintenance of sinus rhythm by antiarrhythmic agents].
Sugi K
J Cardiol; 1999 Mar; 33 Suppl 1():59-64. PubMed ID: 10342138
[TBL] [Abstract][Full Text] [Related]
7. New directions in antiarrhythmic drug therapy for atrial fibrillation.
Heijman J; Voigt N; Dobrev D
Future Cardiol; 2013 Jan; 9(1):71-88. PubMed ID: 23259476
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of atrial remodeling and clinical relevance.
Nattel S; Shiroshita-Takeshita A; Cardin S; Pelletier P
Curr Opin Cardiol; 2005 Jan; 20(1):21-5. PubMed ID: 15596955
[TBL] [Abstract][Full Text] [Related]
9. Novel anti-arrhythmic agents for the treatment of atrial fibrillation.
Wettwer E; Christ T; Dobrev D; Ravens U
Curr Opin Pharmacol; 2007 Apr; 7(2):214-8. PubMed ID: 17303472
[TBL] [Abstract][Full Text] [Related]
10. [Restoration and maintenance of sinus rhythm in patients with atrial fibrillation. New pharmacological approaches].
Runge S; Dietz R; Haverkamp W
Dtsch Med Wochenschr; 2008 Dec; 133(49):2572-8. PubMed ID: 19039713
[TBL] [Abstract][Full Text] [Related]
11. New antiarrhythmic drugs for atrial flutter and atrial fibrillation: a conceptual breakthrough at last?
Cosío FG; Delpón E
Circulation; 2002 Jan; 105(3):276-8. PubMed ID: 11804977
[No Abstract] [Full Text] [Related]
12. New concepts in understanding and modulating atrial repolarisation in patients with atrial fibrillation.
Dobrev D
J Interv Card Electrophysiol; 2008 Aug; 22(2):107-10. PubMed ID: 18330686
[TBL] [Abstract][Full Text] [Related]
13. Model systems for the discovery and development of antiarrhythmic drugs.
Nattel S; Duker G; Carlsson L
Prog Biophys Mol Biol; 2008; 98(2-3):328-39. PubMed ID: 19038282
[TBL] [Abstract][Full Text] [Related]
14. Antiarrhythmic therapy in atrial fibrillation.
Ravens U
Pharmacol Ther; 2010 Oct; 128(1):129-45. PubMed ID: 20624425
[TBL] [Abstract][Full Text] [Related]
15. Electrical remodeling in atrial fibrillation.
Dobrev D
Herz; 2006 Apr; 31(2):108-12; quiz 142-3. PubMed ID: 16738832
[TBL] [Abstract][Full Text] [Related]
16. [Non-channel drugs to prevent atrial fibrillation].
Fazekas T; Liszkai G
Orv Hetil; 2005 Nov; 146(45):2287-94. PubMed ID: 16304807
[TBL] [Abstract][Full Text] [Related]
17. Effects of amiodarone on electrical and structural remodeling induced in a canine rapid pacing-induced persistent atrial fibrillation model.
Ashikaga K; Kobayashi T; Kimura M; Owada S; Sasaki S; Iwasa A; Furukawa K; Motomura S; Okumura K
Eur J Pharmacol; 2006 Apr; 536(1-2):148-53. PubMed ID: 16556442
[TBL] [Abstract][Full Text] [Related]
18. [Pathogenesis and clinical significance of atrial fibrillation].
Fazekas T; Csanádi Z; Varró A
Orv Hetil; 2003 Jan; 144(4):155-63. PubMed ID: 12621813
[TBL] [Abstract][Full Text] [Related]
19. A review of the investigational antiarrhythmic agent dronedarone.
Tafreshi MJ; Rowles J
J Cardiovasc Pharmacol Ther; 2007 Mar; 12(1):15-26. PubMed ID: 17495254
[TBL] [Abstract][Full Text] [Related]
20. [New class III antiarrhythmic drugs for treatment of atrial fibrillation].
Maĭkov EB
Kardiologiia; 2012; 52(11):56-65. PubMed ID: 23237397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
